The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Share News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 422.50
Bid: 415.00
Ask: 430.00
Change: -5.00 (-1.17%)
Spread: 15.00 (3.614%)
Open: 427.50
High: 422.50
Low: 419.00
Prev. Close: 427.50
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tristel's Hospital Surface Disinfection Focus Helps It Weather Virus

Mon, 19th Oct 2020 11:16

(Alliance News) - Infection prevention products provider Tristel PLC on Monday said annual profit grew as hospital surface disinfectant sales helped to offset a decline in medical device decontamination sales.

Revenue for the financial year ended June 30 was GBP31.7 million, up 21% from GBP26.2 million the year before. Pretax profit rose 40% to GBP6.6 million from GBP4.7 million.

"We delivered another very sound performance in a year turned on its head by Covid-19, the impact of which was a reduction of GBP0.5 million in medical device decontamination sales and an increase of GBP2 million in hospital surface disinfectant sales," said Chief Executive Paul Swinney.

During the March to June period, when the impact of Covid-19 was at its greatest, global sales were GBP11.8 million compared to GBP9.1 million in the same period last year, an increase of 30%. Medical device decontamination product sales accounted for 74% of sales in this period, while sales of hospital surface disinfection products accounted for 15%.

Tristel said it was able to steer its way through the early Covid-19 crisis by mitigating the fall in demand for its primary product portfolio via a rapid increase in supply of its hospital surface disinfection products.

Turning to the recently-started financial year, Swinney said the company has seen a "gradual recovery" in demand for medical device products in all its markets in the first quarter.

"Since February, we have acquired a significant number of hospital customers for our surface disinfectant products. We expect this build-up of our hospital surface disinfection business to continue throughout this and future years. It is a key strategic focus of the company," he added.

While further Covid-19 lockdowns may "temporarily interrupt our group's forward momentum", Tristel is optimistic for the year's trading outlook.

Tristel raised its full-year dividend by 12% to 6.18 pence.

Shares in Tristel were up 2.2% at 509.00p in London on Monday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
24 Apr 2014 15:41

Sector movers: Healthcare stocks rise as M&A fever continues

Global M&A activity gave stocks in the healthcare equipment and services a boost on Thursday, with Smith & Nephew rising strongly after a takeover bid for sector peer Biomet. US artificial joint maker Zimmer Holdings announced today that it would buy orthopaedic products group Biomet in a deal valu

Read more
13 Mar 2014 11:17

Tristel Welcomes Call To Tackle Drug-Resistant Organisms

LONDON (Alliance News) - Tristel PLC Thursday welcomed a call from Public Health England calling for NHS Trust chief executives to tackle multi-drug resistant organisms, often called ''superbugs." The circular from the UK Government Department of Health's executive agency, says that "carbap

Read more
3 Mar 2014 11:29

Tristel Hikes Interim Dividend As It Swings To Profit

LONDON (Alliance News) - Tristel PLC Monday raised its interim dividend as it swung into a pretax profit as revenue rose in the half-year ended December 31, 2013, and administrative expenses dropped. Tristel posted an interim dividend of 0.36 pence, up from 0.08 pence in the previous year.<

Read more
22 Jan 2014 13:43

UK MIDDAY BRIEFING: Jobless Rate Falls As UK Recovery Continues

LONDON (Alliance News) - The unemployment rate in the UK declined by more than expected in the three months to November 2013, leading to calls for renewed clarity around forward guidance from Bank of England Governor Mark Carney. Meanwhile, minutes from the BOE's latest Monetary Policy Committ

Read more
22 Jan 2014 10:56

UK WINNERS & LOSERS: Sage Group Leads Blue-Chip Gainers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.

-------

FTSE 100 - WINNERS

Sage Group, up 4.9%. The business-management software company has reve

Read more
22 Jan 2014 08:36

Tristel Shares Jump As It Says Results To Beat Upgraded Expectations

LONDON (Alliance News) - Shares in Tristel rose 16% Wednesday morning after it said it expects to report revenue and pretax profit ahead of previously upgraded expectations for the six months ended December 31, 2013. The biotechnology company said it had seen a strong first half and expects

Read more
10 Dec 2013 11:00

Tristel raises profit expectations after strong first half trading

Hospital hygiene group Tristel has told shareholders that first-half profits will be higher than it expected after strong momentum continued in the UK and overseas. At its annual general meeting, the AIM-listed infection and contamination control provider said it expected to reverse the previous y

Read more
14 Oct 2013 15:40

STOCKS NEWS EUROPE-UK small caps underperform blue-chips

The FTSE Small Caps Index closes flat while junior-listed AIM shares rise 0.1 percent, underperforming a 0.6 percent rise on the mid-caps and a 0.3 percent gain on the blue chips. Tristel gains 7.3 percent after reporting a strong second half performance to round off the year, with revenu

Read more
14 Oct 2013 12:51

UPDATE: Tristel Widens Pretax Losses, Remains Cautiously Optimistic Following Restructuring

Read more
14 Oct 2013 08:32

Tristel Widens Pretax Losses, Remains Cautiously Optimistic Following Restructuring

Read more
14 Oct 2013 07:28

Second-half progress at Tristel

Cambridge-based contamination and infection control products maker Tristel reported full-year results ahead of expectations as a strong second half overshadowed a weak first-half performance. The group, whose Tristel Wipes System is a widely used disinfection method in ENT, Cardiology, IVF and Ult

Read more
18 Jan 2013 13:55

Tristel receives Chinese licence for wipes system

Tristel, a manufacturer of infection prevention, contamination control and hygiene products, has received a licence from the Health Department of the People's Republic of China to import and sell the Tristel Wipes System. The system decontaminates and disinfects non-lumened medical devices, such as

Read more
29 Oct 2012 07:30

Annual profit surge at Tristel

Cambridge based contamination and infection control products maker Tristel ramped up profit for the year ended June 30th 2012 and announced the resignation of Chairman Francisco Soler after 19 years at the helm. The group reported adjusted pre-tax profit of £0.75m for the period, up 48% from the sa

Read more
29 Aug 2012 16:08

Centamin director stocks up following increased gold production

Senior Independent Non-Executive Director at Centamin, Gordon Edward Haslam, purchased 52,056 shares in the Egypt-focused gold miner on Wednesday. Haslam purchased the shares at 76p each for a total of £39,563, taking his total holding to 102,056 shares. The transaction comes two weeks after the

Read more
23 Jul 2012 07:55

Tristel lifts full year forecast

Contamination and infection control products maker Tristel said it expects full year profit to come in ahead of previous forecasts after a strong performance across all of the group's divisions in late June. Results to 30 June 2012 will now show adjusted pre-tax profits in excess of £700,000. Last

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.